期刊文献+

恶性胸腔积液患者T淋巴细胞亚群的变化意义 被引量:4

Value of measurement of T-lymphocyte subsets in patients with malignant pleural effusions
下载PDF
导出
摘要 目的:探讨检测恶性胸腔积液(MPE)患者外周血(PB)和胸水(PE)中T淋巴细胞亚群(TLS)的意义及化疗前后TLS的变化.方法:对比良性胸腔积液(BPE)、MPE患者外周血和胸水及健康正常人外周血中TLS的水平;对比MPE患者外周血和胸水中TLS的水平;对比MPE患者化疗前、后外周血和胸水中TLS的水平.结果:TLS在胸腔积液患者外周血和胸水中分布相似;MPE患者外周血中CD8+T细胞水平高于正常人(30.6±2.4vs20.9±1.8,P<0.05),CD4+T细胞相仿,CD4+/CD8+低于正常(1.78±0.21vs2.71±0.35,P<0.05);与BPE患者相比,MPE患者外周血和胸水中CD4+T细胞、CD4+/CD8+较低(P<0.05),而CD8+T细胞较高(P<0.05);化疗后MPE患者外周血和胸水中CD8+T细胞水平明显降低(30.6±2.4vs24.7±2.3,31.6±2.4vs21.9±4.1,P<0.05),CD4+/CD8+明显升高(1.78±0.21vs2.19±0.19,1.69±0.30vs2.62±0.40,P<0.05).结论:检测外周血可以了解胸水中TLS水平;检测外周血和胸水中TLS水平有助于BPE和MPE的鉴别;化疗可部分改善MPE患者的细胞免疫抑制状态. AIM: To measure T-lymphocyte subsets (TLS) in peripheral blood (PB) and pleural effusion (PE) in patients with malignant pleural effusions (MPE) and to study the changes of TLS in PB and PE in patients with MPE before and after chemotherapy. METHODS: The levels of TLS in PB and PE in patients with MPE or benign pleural effusion (BPE) and in PB of normal person were examined and compared; The levels of TLS in PB and PE were also compared before and after chemotherapy. RESULTS: The distribution of TLS was similar in PB and PE in patients with MPE; the level of CD8^+ T cell in PB of patients with MPE was higher than that in normal person ( 30. 6 ± 2. 4 vs 20.9 ± 1.8, P 〈0.05), but the ratio of CD4^+/CD8^+ was lower than that in normal person ( 1.78± 0. 21 vs 2.71 ± 0. 35, P 〈 0.05 ), and the level of CD4^+ T cell was similar with the normal; compared with BPE patients, MPE ones had lower level of CD4^+ T cell and ratio of CD4^+/CD8^+ ( P 〈 0.05 ), but higher level of CD8^+ T cell in their PB and PE (P 〈 0. 05) ; chemotherapy could depress CD8^+ T cell (30.6 ±2.4 vs 24.7 ±2.3, 31.6 ±2.4 vs 21.9±4. 1, P 〈0.05) and elevate the ratio of CD4^+/CD8^+ (1.78 ±0.21 vs 2. 19 ±0. 19, 1.69 ±0.30 vs 2.62±0.40, P〈 0. 05) in PB and PE in patients with MPE. CONCLUSION: The level of TLS in PE can be known by measuring it in PB; it is helpful to measure the level of TLS in PB and PE for distinguishing MPE from BPE; cell-mediated immunity depression in MPE can be partly ameliorated by chemotherapy.
出处 《第四军医大学学报》 北大核心 2007年第5期447-449,共3页 Journal of the Fourth Military Medical University
关键词 胸腔积液 T淋巴细胞 CD4 CD8 pleural effusion T-lymphocyte CD4 CD8
  • 相关文献

参考文献5

  • 1萧剑军,何洁冰,何庭宇,彭杰文,雷风.中晚期肺癌患者T淋巴细胞亚群和红细胞免疫功能检测及临床意义[J].广东医学院学报,2002,20(1):15-16. 被引量:7
  • 2Sigstad E,Dong HP,Nielsen S,et al.Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping[J].Diagn Cytopathol,2005,33(5):325-331.
  • 3Chen YQ,Shi HZ,Qin XJ,et al.CD4^+ CD25^+ regulatory T lymphocytes in malignant pleural effusion[J].Am J Respir Crit Care Med,2005,172(11):1434-1439.
  • 4Dalbeth N,Lee YC.Lymphocytes in pleural disease[J].Curr Opin Pulm Med,2005,11(4):334-339.
  • 5Ahmed S,Shahid RK,Rimawi R,et al.Malignant pleural effusions in lymphoproliferative disorders[J].Leuk Lymphoma,2005,46(7):1039-1044.

二级参考文献13

共引文献6

同被引文献28

  • 1Sumi M,Kagohashi K,Satoh H,et al.Endostatin levels in exudative pleural effusions[J].Lung,2005,181:329 - 334.
  • 2Takigawa N, Segawa Y, Fujimoto N,et al.Elevated vascular endothelial growth factor levels in sera ofpatients with lung cancer[J]. Anticancer Res,1998,18:1251 - 1254.
  • 3Kuss I, Hathway B,Ferris RL,et al. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck[J]. Clin Cancer Res, 2004,10 ( 11 ) : 3755-3762.
  • 4Morisaki T, Matsumoto K, Kuroki H, et al. Combined immuno- therapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion [J]. Anticancer Res, 2003, 23 (6a) :4459-4465.
  • 5Brown IE,Blank C, Kline J, et al. Homeostatic proliferation as an isolated variable reverses CD8 + T cell anergy and promotes tumor rejection[J]. J Immunol,2006,177(7) :4521-4529.
  • 6Beyer M, Kochanek M, Darabi K, et al. Reduced frequencies and suppressive function of CIM+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine[J]. Blood, 2005,106(6) : 2018-2025.
  • 7Vicari AP,Luu R,Zhang N,et al. Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the antitumor effects of the TLR9 agonist PF-3512676 in the mouse [J]. Cancer Immunol Immunother,2009,58(4) :615-628.
  • 8Ishimoto O,Saijo Y, Narumi K, et al. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer[J]. Oncology,2002,63 (1) : 70-75.
  • 9Ruiz E, Alemdn C, Alegre J, et al. Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions[J]. Lung, 2005,183(3) :185-195.
  • 10Stathopoulos GT, Moschos C, Loutrari H, et al. Zoledronie acid is eVective against experimental malignant pleural effusion[J]. Am J Respir Crit Care Med,2008,178(1) :50-59.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部